LFMD

LifeMD, Inc.

$1.74

-16.95%
SectorHealthcareIndustryHealth Information ServicesCountryUnited States

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss.

Source: Yahoo Finance
AI summary

Price & performance

1M-19.4%
3M-36.3%
YTD-33.5%
1Y-62.1%
52-week range—
Beta1.69
Full chart and returns against a benchmark

Q-Score

46/ 100

Quality against peers; 50 is the peer median.

Growth47
Risk43
Performance38
Valuation57
Profitability68
Leverage38
Sentiment29
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$194.1M+25.3%
Net income$14.4M
Net margin7.4%+21.2 pts
Historical fundamentals

Red flags in filings

3active red flags
Material weakness in controlsMar 10, 2026
Late filing noticeNov 12, 2025
Auditor changeAug 21, 2025
Filings, findings and the timeline

Revenue exposure

0%of revenue from outside the US
United States100%
Regions, segments, customers and suppliers

Valuation

LFMDIndustryP/E417.7167.40P/S0.444.25EV/EBITDA—44.97P/B10.546.14PEG—0.25
Dividend yield3.70%
Every valuation metric

Earnings

Nov 12next report, after the close
EPS estimate$-0.01
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate